SCHEMBL5190975

SCHEMBL5190975

O=C(Nc1cccs1)c1ccnc2ccccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.48
ALDH1A1 P00352 4/20 0.45
MAPT P10636 3/20 0.45
HTT P42858 2/20 0.45
RAB9A P51151 2/20 0.45
HSP90AA1 P07900 1/20 0.45
ATM Q13315 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
MAPK1 P28482 1/20 0.45
NSD2 O96028 1/20 0.45
CNR1 P21554 1/20 0.45
CNR2 P34972 1/20 0.45
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
LMNA P02545 2/20 0.44
HPGD P15428 1/20 0.44
NR2E1 Q9Y466 1/20 0.43
PABPC1 P11940 1/20 0.43
EIF4H Q15056 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL379808 0.78 CYP3A4 (0.60) ALDH1A1MAPTHTTNPSR1NSD2
SCHEMBL6928574 0.77 MEN1 (0.56) NPC1ALDH1A1MAPTRAB9ASMN1; SMN2
SCHEMBL8573837 0.74 NSD2 (0.56) NSD2CNR1CNR2NR2E1HDAC3
SCHEMBL5603305 0.74 NSD2 (0.56) ALDH1A1NSD2CNR1CNR2HDAC3
SCHEMBL3486560 0.73 MAPK1 (0.62) NPC1ALDH1A1MAPTHTTRAB9A
SCHEMBL7784318 0.73 DNMT1 (0.65) HTTNR2E1L3MBTL1ACLY
Hydrochloric Acid SCHEMBL28349289 0.73 NSD2 (0.55) NSD2CNR1CNR2NR2E1HDAC3
SCHEMBL1876691 0.73 NPC1 (0.63) NPC1ALDH1A1MAPTRAB9ASMN1; SMN2
SCHEMBL23193358 0.71 NCF1 (0.50) NPC1MAPTRAB9ASMN1; SMN2NSD2
SCHEMBL5271311 0.71 NSD2 (0.52) NSD2CNR1CNR2NR2E1HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1812398-A1 COMPOUNDS HAVING ACTIVITY AT NK3 RECEPTOR AND USES THEREOF IN MEDICINE SmithKline Beecham Corporation (US) 2007-08-01 EP claimed
WO-2006050992-A1 COMPOUNDS HAVING ACTIVITY AT NK3 RECEPTOR AND USES THEREOF IN MEDICINE SMITHKLINE BEECHAM CORPORATION (US) 2006-05-18 WO claimed
EP-1812398-A1 COMPOUNDS HAVING ACTIVITY AT NK3 RECEPTOR AND USES THEREOF IN MEDICINE SmithKline Beecham Corporation (US) 2007-08-01 EP disclosed
WO-2006050992-A1 COMPOUNDS HAVING ACTIVITY AT NK3 RECEPTOR AND USES THEREOF IN MEDICINE SMITHKLINE BEECHAM CORPORATION (US) 2006-05-18 WO disclosed